These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35985924)

  • 41. Evaluation of multi-level barriers and facilitators in a large diabetic retinopathy screening program in federally qualified health centers: a qualitative study.
    Bastos de Carvalho A; Lee Ware S; Belcher T; Mehmeti F; Higgins EB; Sprang R; Williams C; Studts JL; Studts CR
    Implement Sci Commun; 2021 May; 2(1):54. PubMed ID: 34022946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Teleophthalmology provides earlier eye care access for patients with newly-diagnosed diabetes.
    Lieng MK; Emami-Naeini P; Lee SC; Alber S; Yiu G
    Heliyon; 2024 Feb; 10(4):e25845. PubMed ID: 38384560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetic retinopathy screenings in West Virginia: an assessment of teleophthalmology implementation.
    Schofield T; Patel A; Palko J; Ghorayeb G; Laxson LC
    BMC Ophthalmol; 2023 Mar; 23(1):93. PubMed ID: 36899342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population.
    Aoki N; Dunn K; Fukui T; Beck JR; Schull WJ; Li HK
    Diabetes Care; 2004 May; 27(5):1095-101. PubMed ID: 15111527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic retinopathy screening with pharmacy-based teleophthalmology in a semiurban setting: a cost-effectiveness analysis.
    Coronado AC; Zaric GS; Martin J; Malvankar-Mehta M; Si FF; Hodge WG
    CMAJ Open; 2016; 4(1):E95-E102. PubMed ID: 27280120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers and enablers to diabetic retinopathy screening attendance: Protocol for a systematic review.
    Graham-Rowe E; Lorencatto F; Lawrenson JG; Burr J; Grimshaw JM; Ivers NM; Peto T; Bunce C; Francis JJ;
    Syst Rev; 2016 Aug; 5(1):134. PubMed ID: 27515938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Healthcare providers' perspectives on perceived barriers and facilitators of compassion: Results from a grounded theory study.
    Singh P; Raffin-Bouchal S; McClement S; Hack TF; Stajduhar K; Hagen NA; Sinnarajah A; Chochinov HM; Sinclair S
    J Clin Nurs; 2018 May; 27(9-10):2083-2097. PubMed ID: 29575539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Teleophthalmology in Diabetic Retinopathy.
    Surendran TS; Raman R
    J Diabetes Sci Technol; 2014 Mar; 8(2):262-266. PubMed ID: 24876576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy Screening.
    Sim DA; Mitry D; Alexander P; Mapani A; Goverdhan S; Aslam T; Tufail A; Egan CA; Keane PA
    J Diabetes Sci Technol; 2016 Feb; 10(2):308-17. PubMed ID: 26830492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Healthcare Outcomes of Patients and Antecedents via Teleophthalmology in Eastern Taiwan during COVID-19.
    Chen HC; Chang CY; Tsai CH; Hsu WL; Sung WF; Wu YX
    Healthcare (Basel); 2024 Aug; 12(16):. PubMed ID: 39201230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Systematic Review of Current Teleophthalmology Services in New Zealand Compared to the Four Comparable Countries of the United Kingdom, Australia, United States of America (USA) and Canada.
    Walsh L; Hong SC; Chalakkal RJ; Ogbuehi KC
    Clin Ophthalmol; 2021; 15():4015-4027. PubMed ID: 34675470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and severity of diabetic retinopathy in Northwest Cameroon as identified by teleophthalmology.
    Jivraj I; Ng M; Rudnisky CJ; Dimla B; Tambe E; Nathoo N; Tennant MT
    Telemed J E Health; 2011 May; 17(4):294-8. PubMed ID: 21457121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 15 month experience with a primary care-based telemedicine screening program for diabetic retinopathy.
    Benjamin JE; Sun J; Cohen D; Matz J; Barbera A; Henderer J; Cheng L; Grachevskaya J; Shah R; Zhang Y
    BMC Ophthalmol; 2021 Feb; 21(1):70. PubMed ID: 33541295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AI-Human Hybrid Workflow Enhances Teleophthalmology for the Detection of Diabetic Retinopathy.
    Dow ER; Khan NC; Chen KM; Mishra K; Perera C; Narala R; Basina M; Dang J; Kim M; Levine M; Phadke A; Tan M; Weng K; Do DV; Moshfeghi DM; Mahajan VB; Mruthyunjaya P; Leng T; Myung D
    Ophthalmol Sci; 2023 Dec; 3(4):100330. PubMed ID: 37449051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barriers to Implementation of Teleretinal Diabetic Retinopathy Screening Programs Across the University of California.
    Chen JS; Lin MC; Yiu G; Thorne C; Kulasa K; Stewart J; Nudleman E; Freeby M; Han MA; Baxter SL
    Telemed J E Health; 2023 Dec; 29(12):1810-1818. PubMed ID: 37256712
    [No Abstract]   [Full Text] [Related]  

  • 57. Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings.
    Piyasena MMPN; Murthy GVS; Yip JLY; Gilbert C; Zuurmond M; Peto T; Gordon I; Hewage S; Kamalakannan S
    PLoS One; 2019; 14(4):e0198979. PubMed ID: 31013274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A qualitative study to explore healthcare providers' perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa.
    Tshabalala G; Blanchard C; Mmoledi K; Malope D; O'Neil DS; Norris SA; Joffe M; Dietrich JJ
    PLOS Glob Public Health; 2023; 3(5):e0001826. PubMed ID: 37159437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient, family member, and health care provider perspective on barriers and facilitators to diabetic retinopathy screening in Thailand: A qualitative study.
    Kumar G; Velu S; Pardhan S; Sapkota R; Ruamviboonsuk P; Tadarati M; Chotcomwongse P; Nganthavee V; Pattanapongpaiboon W; Raman R
    PLoS One; 2023; 18(8):e0289618. PubMed ID: 37535658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost Analysis of Teleophthalmology Screening for Diabetic Retinopathy Using Teleophthalmology Billing Codes.
    Ellis MP; Bacorn C; Luu KY; Lee SC; Tran S; Lillis C; Lim MC; Yiu G
    Ophthalmic Surg Lasers Imaging Retina; 2020 May; 51(5):S26-S34. PubMed ID: 32484898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.